Literature DB >> 32389217

Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group.

Eric Faulkner1, Anke-Peggy Holtorf2, Surrey Walton3, Christine Y Liu4, Hwee Lin5, Eman Biltaj6, Diana Brixner6, Charles Barr7, Jennifer Oberg8, Gurmit Shandhu9, Uwe Siebert10, Susan R Snyder11, Simran Tiwana12, John Watkins13, Maarten J IJzerman14, Katherine Payne15.   

Abstract

Precision medicine is a dynamic area embracing a diverse and increasing type of approaches that allow the targeting of new medicines, screening programs or preventive healthcare strategies, which include the use of biologic markers or complex tests driven by algorithms also potentially taking account of patient preferences. The International Society for Pharmacoeconomics and Outcome Research expanded its current work around precision medicine to (1) describe the evolving paradigm of precision medicine with examples of current and evolving applications, (2) describe key stakeholders perspectives on the value of precision medicine in their respective domains, and (3) define the core factors that should be considered in a value assessment framework for precision medicine. With the ultimate goal of improving health of well-defined patient groups, precision medicine will affect all stakeholders in the healthcare system at multiple levels spanning the individual perspective to the societal perspective. For an efficient, timely and practical precision medicine value assessment framework, it will be important to address these multiple perspectives through building consensus among the stakeholders for robust procedures and measures of value aspects, including performance of precision mechanism; aligned reimbursement processes of precision mechanism and subsequent treatment; transparent expectations for evidence requirements and study designs adequately matched to the intended use of the precision mechanism and to the smaller target patient populations; recognizing the potential range of value-generation such as ruling-in and ruling-out decisions.
Copyright © 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  health technology assessment; precision medicine and diagnostics; value frameworks

Year:  2020        PMID: 32389217     DOI: 10.1016/j.jval.2019.11.010

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  14 in total

1.  Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy.

Authors:  Kathryn A Phillips
Journal:  Value Health       Date:  2020-04-17       Impact factor: 5.725

2.  Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access.

Authors:  Patricia A Deverka; Michael P Douglas; Kathryn A Phillips
Journal:  Health Aff (Millwood)       Date:  2022-03       Impact factor: 6.301

Review 3.  Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine.

Authors:  Habiba Abdelhalim; Asude Berber; Mudassir Lodi; Rihi Jain; Achuth Nair; Anirudh Pappu; Kush Patel; Vignesh Venkat; Cynthia Venkatesan; Raghu Wable; Matthew Dinatale; Allyson Fu; Vikram Iyer; Ishan Kalove; Marc Kleyman; Joseph Koutsoutis; David Menna; Mayank Paliwal; Nishi Patel; Thirth Patel; Zara Rafique; Rothela Samadi; Roshan Varadhan; Shreyas Bolla; Sreya Vadapalli; Zeeshan Ahmed
Journal:  Front Genet       Date:  2022-07-06       Impact factor: 4.772

Review 4.  Delivering precision oncology to patients with cancer.

Authors:  Joaquin Mateo; Lotte Steuten; Philippe Aftimos; Fabrice André; Mark Davies; Elena Garralda; Jan Geissler; Don Husereau; Iciar Martinez-Lopez; Nicola Normanno; Jorge S Reis-Filho; Stephen Stefani; David M Thomas; C Benedikt Westphalen; Emile Voest
Journal:  Nat Med       Date:  2022-04-19       Impact factor: 87.241

5.  Avoiding "toxic knowledge": the importance of framing personalized risk information in clinical decision-making.

Authors:  Kristin M Kostick; J S Blumenthal-Barby
Journal:  Per Med       Date:  2021-02-22       Impact factor: 2.512

6.  Complicated legacies: The human genome at 20.

Authors:  Kathryn Maxson Jones; Robert Cook-Deegan; Charles N Rotimi; Shawneequa L Callier; Amy R Bentley; Hallam Stevens; Kathryn A Phillips; Jeroen P Jansen; Christopher F Weyant; Dorothy E Roberts; Dina Zielinski; Yaniv Erlich; Nanibaa' A Garrison; Stephanie Russo Carroll; Pilar N Ossorio; Yves Moreau; Maya Wang
Journal:  Science       Date:  2021-02-04       Impact factor: 63.714

7.  Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.

Authors:  Rositsa Koleva-Kolarova; James Buchanan; Heleen Vellekoop; Simone Huygens; Matthijs Versteegh; Maureen Rutten-van Mölken; László Szilberhorn; Tamás Zelei; Balázs Nagy; Sarah Wordsworth; Apostolos Tsiachristas
Journal:  Appl Health Econ Health Policy       Date:  2022-04-04       Impact factor: 3.686

8.  Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late.

Authors:  Maarten J IJzerman; Jasper de Boer; Arun Azad; Koen Degeling; Joel Geoghegan; Chelsee Hewitt; Frédéric Hollande; Belinda Lee; Yat Ho To; Richard W Tothill; Gavin Wright; Jeanne Tie; Sarah-Jane Dawson
Journal:  Diagnostics (Basel)       Date:  2021-01-11

Review 9.  Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice.

Authors:  J Kevin Hicks; Rachel Howard; Phillip Reisman; Jacob J Adashek; Karen K Fields; Jhanelle E Gray; Bryan McIver; Kelly McKee; Mandy F O'Leary; Randa M Perkins; Edmondo Robinson; Ankita Tandon; Jamie K Teer; Joseph Markowitz; Dana E Rollison
Journal:  JCO Precis Oncol       Date:  2021-05-20

Review 10.  Utility of Genetic Testing from the Perspective of Parents/Caregivers: A Scoping Review.

Authors:  Robin Z Hayeems; Stephanie Luca; Daniel Assamad; Ayushi Bhatt; Wendy J Ungar
Journal:  Children (Basel)       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.